)
The Joint Corp (JYNT) investor relations material
The Joint Corp Q3 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Q3 2025 revenue grew 6% year-over-year to $13.4 million, with net income improving to $0.9 million from a $3.2 million loss in Q3 2024, and Adjusted EBITDA rising 36% to $3.3 million, driven by cost optimization and refranchising.
The company is transitioning to a pure-play franchisor model, advancing refranchising of corporate clinics, and executing major sales in key markets, including a pending $4.5 million transaction for 45 clinics in Southern California.
System-wide sales declined 1.5% to $127.3 million and comparable sales fell 2.0% year-over-year, attributed to lower new patient counts and broader market challenges.
Strategic initiatives include a national marketing campaign focused on pain relief, digital marketing transformation, a three-tiered pricing pilot for wellness plans, and a new mobile app with 178,000 downloads and 18% adoption among new patients.
The board authorized an additional $12 million for share repurchases, with 540,000 shares repurchased for $5 million to date.
Financial highlights
Q3 2025 revenue was $13.4 million, up 6% year-over-year; nine-month revenue reached $39.7 million, a 6.1% increase.
Q3 2025 net income was $0.9 million, reversing a $3.2 million loss in Q3 2024; nine-month net income was $1.9 million versus a $5.8 million loss in the prior year.
Adjusted EBITDA for Q3 2025 was $3.3 million, up 36% year-over-year; nine-month consolidated Adjusted EBITDA was $9.4 million, up 16%.
Unrestricted cash at quarter-end was $29.7 million, up from $25.1 million at year-end 2024.
No outstanding debt; $20 million undrawn line of credit available through August 2027.
Outlook and guidance
2025 system-wide sales guidance revised to $530–$534 million, down from prior $530–$550 million.
Comparable sales guidance for 2025 is -1% to 0%, revised from prior low single-digit growth.
Consolidated Adjusted EBITDA guidance maintained at $10.8–$11.8 million; new franchised clinic openings expected at 30–35.
2026 continuing operations expected to be more profitable due to refranchising and cost realignment.
Management anticipates continued macroeconomic volatility, with inflation and labor shortages as key challenges.
Next The Joint Corp earnings date
Next The Joint Corp earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage